US 11021710
Compounds and methods for reducing FXI expression
granted A61KA61K31/70A61K31/7088
Quick answer
US patent 11021710 (Compounds and methods for reducing FXI expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/70, A61K31/7088